ESCUELA ANDALUZA DE SALUD PUBLICA SA

Their core work

The Andalusian School of Public Health (EASP) is a Spanish public health institution based in Granada that specializes in health systems research, policy analysis, and professional training. Their core work spans health technology assessment, human biomonitoring, and the translation of research evidence into health policy. They bring particular strength in evaluating how health interventions perform in real-world settings and in assessing the societal dimensions of health — including equity, patient preferences, and rights-based approaches to healthcare.

What they specialise in

How they've shifted over time

EASP's early H2020 work (2016–2018) centered on environmental health — specifically human biomonitoring, chemical exposure assessment, and connected health technologies. From 2018 onward, their focus shifted decisively toward health systems evaluation (HTA methods, costing, patient preferences) and social dimensions of health (intersex rights, equality, diversity). This trajectory suggests a move from monitoring health risks to actively shaping how health systems respond to them.

EASP is moving toward rights-based and equity-focused health research, making them a strong partner for projects addressing health disparities, inclusive healthcare, and socially responsible HTA.

How they like to work

EASP never coordinates H2020 projects — they consistently join as participant or third party in large, multi-country consortia. With 146 unique partners across 30 countries, they connect broadly rather than deeply with a small circle. This pattern suggests an organization that contributes specialized public health expertise to diverse teams without seeking to lead the administrative burden, making them a low-friction addition to large consortia.

EASP has collaborated with 146 unique partners across 30 countries, giving them one of the wider networks relative to their project count. Their reach is genuinely pan-European, driven by participation in large-scale initiatives like HBM4EU that span most EU member states.

What sets them apart

EASP sits at the intersection of public health science and policy application — they don't just produce research, they specialize in making it usable for decision-makers. Their combination of health technology assessment expertise with a growing focus on health equity and human rights is unusual for a Spanish institution of this type. For consortium builders, they fill the critical gap between clinical/technical workpackages and policy impact deliverables.

Highlights from their portfolio

• INIA
  Their largest single grant (EUR 501,810) tackles the underserved topic of intersex health through an interdisciplinary lens combining medicine, law, and human rights.
• IMPACT HTA
  Core HTA methodology project (EUR 416,250) addressing practical tools for value assessment, costing, and real-world evidence — directly applicable to health policy across Europe.
• HBM4EU
  Flagship European biomonitoring initiative involving hundreds of partners; EASP's participation (as third party) connects them to the continent's largest chemical exposure surveillance network.